Private Advisor Group LLC grew its stake in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 9,220.4% during the third quarter, Holdings Channel reports. The institutional investor owned 131,325 shares of the medical equipment provider’s stock after buying an additional 129,916 shares during the period. Private Advisor Group LLC’s holdings in Align Technology were worth $17,402,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds also recently made changes to their positions in the stock. Ieq Capital LLC raised its stake in Align Technology by 280.1% during the 3rd quarter. Ieq Capital LLC now owns 198,176 shares of the medical equipment provider’s stock worth $26,443,000 after acquiring an additional 146,042 shares during the period. Colonial Trust Co SC lifted its holdings in Align Technology by 254,205.6% during the third quarter. Colonial Trust Co SC now owns 45,775 shares of the medical equipment provider’s stock valued at $6,057,000 after purchasing an additional 45,757 shares in the last quarter. Boston Partners boosted its position in shares of Align Technology by 42.1% in the third quarter. Boston Partners now owns 92,352 shares of the medical equipment provider’s stock worth $12,325,000 after purchasing an additional 27,375 shares during the period. Meeder Asset Management Inc. boosted its position in shares of Align Technology by 25,344.4% in the third quarter. Meeder Asset Management Inc. now owns 6,870 shares of the medical equipment provider’s stock worth $910,000 after purchasing an additional 6,843 shares during the period. Finally, Impax Asset Management Group plc bought a new position in shares of Align Technology in the third quarter worth approximately $1,875,000. 88.43% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
A number of analysts have recently issued reports on ALGN shares. Needham & Company LLC reissued a “hold” rating on shares of Align Technology in a research note on Thursday, October 29th. Piper Sandler lowered their target price on shares of Align Technology from $235.00 to $205.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 21st. Zacks Research raised shares of Align Technology from a “strong sell” rating to a “hold” rating in a report on Friday, November 13th. Leerink Partners dropped their target price on shares of Align Technology from $235.00 to $215.00 and set an “outperform” rating for the company in a report on Wednesday, October 14th. Finally, Mizuho cut their price target on Align Technology from $220.00 to $200.00 and set an “outperform” rating for the company in a research note on Thursday, October 22nd. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $193.08.
View Our Latest Stock Report on Align Technology
Align Technology Price Performance
Shares of ALGN opened at $155.13 on Friday. The firm has a market cap of $10.94 billion, a P/E ratio of 22.58, a price-to-earnings-growth ratio of 2.15 and a beta of 1.74. Align Technology, Inc. has a 1 year low of $132.63 and a 1 year high of $200.43. The company has a 50 day simple moving average of $152.50 and a two-hundred day simple moving average of $168.54.
Align Technology (NASDAQ:ALGN – Get Free Report) last released its earnings results on Wednesday, October 28th. The medical equipment provider reported $2.80 EPS for the quarter, topping the consensus estimate of $2.77 by $0.03. Align Technology had a net margin of 11.83% and a return on equity of 15.96%. The firm had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1 billion. During the same quarter in the previous year, the firm earned $2.61 earnings per share. The company’s quarterly revenue was up 1.9% compared to the same quarter last year. On average, sell-side analysts anticipate that Align Technology, Inc. will post 9.21 earnings per share for the current year.
Align Technology Profile
Align Technology, Inc. develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning. Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.
Recommended Stories
- Five stocks we like better than Align Technology
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
- MarketBeat Week in Review – 11/16 – 11/20
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN – Free Report).
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.
